Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 7053
MIM: 600238
HGNC: 11779
Ensembl: ENSG00000125780
Variants:
dbSNP: 7053
ClinVar: 7053
TCGA: ENSG00000125780
COSMIC: TGM3
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000125780 | ENST00000381458 | Q08188 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37812238 | 2024 | Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway. | 0 |
| 37812238 | 2024 | Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway. | 0 |
| 37424036 | 2023 | Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis. | 3 |
| 37424036 | 2023 | Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis. | 3 |
| 34597849 | 2022 | Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile. | 0 |
| 36356335 | 2022 | Circular RNA ciRS-7 promotes laryngeal squamous cell carcinoma development by inducing TGM3 hypermethylation via miR-432-5p/DNMT3B axis. | 2 |
| 34597849 | 2022 | Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile. | 0 |
| 36356335 | 2022 | Circular RNA ciRS-7 promotes laryngeal squamous cell carcinoma development by inducing TGM3 hypermethylation via miR-432-5p/DNMT3B axis. | 2 |
| 33899115 | 2021 | Downregulation of miR‑106b‑3p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3. | 1 |
| 33959126 | 2021 | T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis. | 2 |
| 33899115 | 2021 | Downregulation of miR‑106b‑3p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3. | 1 |
| 33959126 | 2021 | T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis. | 2 |
| 31425706 | 2020 | Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN. | 11 |
| 31822388 | 2020 | TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. | 9 |
| 32020212 | 2020 | TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer. | 14 |
Citation
Dessen P
TGM3 (transglutaminase 3)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/46285/tgm3
